Literature DB >> 16091018

13C- and 2H-labelled glucose compared for minimal model estimates of glucose metabolism in man.

Leslie J C Bluck1, Allan T Clapperton, W Andy Coward.   

Abstract

In the present study, we have investigated the use of 1-[(13)C]glucose and GC/combustion/isotope-ratio MS as an alternative to 6,6-[(2)H(2)]glucose and GC/MS in the determination of parameters of glucose metabolism using the IVGTT (intravenous glucose tolerance test) interpreted by labelled (hot) minimal models. The study has been done in four populations, normoglycaemics (subdivided into lean and obese individuals), subjects with impaired glucose tolerance and those with diabetes mellitus. Although the use of carbon label may in some circumstances be compromised by substrate recycling, our hypothesis was that this would not be an issue under the condition of suppression of hepatic glucose production during the short timescale of an IVGTT. In all four groups, we found that the methodology employing the carbon label gave equivalent results to those obtained using the conventional deuterated material, but the sensitivity of the measurement technique in the new approach was sufficient to allow an approx. 15-fold reduction in the quantity of isotope administered. In addition to the clear cost advantages, this represents a significant scientific advance in that true tracer status is more nearly attained in these measurements with near-physiological tracee loads.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091018     DOI: 10.1042/CS20050155

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  8 in total

1.  A convenient LC-MS method for assessment of glucose kinetics in vivo with D-[13C6]glucose as a tracer.

Authors:  Haoyue Zhang; Robert D Stevens; Sarah P Young; Richard Surwit; Anastasia Georgiades; Raymond Boston; David S Millington
Journal:  Clin Chem       Date:  2009-01-30       Impact factor: 8.327

Review 2.  Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization.

Authors:  Kayvan R Keshari; David M Wilson
Journal:  Chem Soc Rev       Date:  2013-12-20       Impact factor: 54.564

Review 3.  Fundamentals about onset and progressive disease character of type 2 diabetes mellitus.

Authors:  Rob Nm Weijers
Journal:  World J Diabetes       Date:  2020-05-15

4.  Estimation of Insulin Resistance in Mexican Adults by the [(13)C]Glucose Breath Test Corrected for Endogenous Total CO(2) Production.

Authors:  Erika Ibarra-Pastrana; Maria Del Carmen Candia Plata; Gerardo Alvarez; Mauro E Valencia
Journal:  Int J Endocrinol       Date:  2012-07-17       Impact factor: 3.257

5.  Impact of short term consumption of diets high in either non-starch polysaccharides or resistant starch in comparison with moderate weight loss on indices of insulin sensitivity in subjects with metabolic syndrome.

Authors:  Gerald E Lobley; Grietje Holtrop; David M Bremner; A Graham Calder; Eric Milne; Alexandra M Johnstone
Journal:  Nutrients       Date:  2013-06-10       Impact factor: 5.717

6.  Insulin sensitivity assessed by stable isotopes with oral glucose administration: validation with euglycaemic clamp.

Authors:  Leslie Bluck; Rachel Williams; Sarah Jackson; Burak Salgin; Carlo Acerini; David Dunger
Journal:  ISRN Endocrinol       Date:  2013-11-03

7.  Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.

Authors:  D Elleri; M Biagioni; J M Allen; K Kumareswaran; L Leelarathna; K Caldwell; M Nodale; M E Wilinska; A Haidar; P Calhoun; C Kollman; N C Jackson; A M Umpleby; C L Acerini; D B Dunger; R Hovorka
Journal:  Diabetes Obes Metab       Date:  2015-10-09       Impact factor: 6.577

Review 8.  Membrane flexibility, free fatty acids, and the onset of vascular and neurological lesions in type 2 diabetes.

Authors:  Rob N M Weijers
Journal:  J Diabetes Metab Disord       Date:  2016-04-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.